Purpose: A case of hypokalemic rhabdomyolysis related to chlorthalidone use is reported CASE SUMMARY: A 52-year-old male was admitted to the hospital for acute onset generalized weakness and was found to have severe hypokalemia and rhabdomyolysis. The patient had been on chlorthalidone therapy with a dose increase from 25 mg daily to 50 mg daily 2 months prior to admission. Extensive workup ruled out neurologic, rheumatologic, and endocrinologic causes of hypokalemia. In the absence of other causes, it was determined that the patient was experiencing a severe presentation of chlorthalidone-induced hypokalemia resulting in rhabdomyolysis. The patient's rhabdomyolysis and weakness improved with aggressive potassium correction, and potassium wasting eventually resolved with discontinuation of chlorthalidone.
Conclusion: Although mild hypokalemia is a known side effect of thiazide and thiazide-like diuretics, health care providers should be aware of the possibility of severe manifestations of this adverse reaction, even at relatively small dose increases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.japh.2024.102249 | DOI Listing |
BMJ Case Rep
October 2024
Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
A woman with a history of chronic idiopathic constipation and remote eating disorders presented to our hospital with generalised weakness and confusion due to severe hypokalaemic rhabdomyolysis. Her initial ECG showed down-sloping ST segment elevations consistent with the 'shark fin' sign, and initial echocardiography was consistent with Takotsubo cardiomyopathy (TCM). She later developed hypotension, hypoxaemia and low central venous oxygen saturation consistent with cardiogenic shock.
View Article and Find Full Text PDFJ Med Case Rep
August 2024
Department of Endocrinology, Tianjin Hospital, 406 Jiefang South Road, Tianjin, 300210, China.
Arch Med Sci
June 2024
Department of Ambulatory Surgical Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Hunan, China.
Cureus
September 2023
Neurology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, IND.
Gitelman syndrome (GS) is a rare renal tubulopathy, classically characterized by renal salt wasting and metabolic alkalosis. It is usually an incidental diagnosis, being asymptomatic or with mild symptoms. GS manifesting with acute flaccid paralysis is extremely uncommon.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!